Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Predictors of mortality in chronic pulmonary aspergillosis.

Lowes D, Al-Shair K, Newton PJ, Morris J, Harris C, Rautemaa-Richardson R, Denning DW.

Eur Respir J. 2017 Feb 8;49(2). pii: 1601062. doi: 10.1183/13993003.01062-2016. Print 2017 Feb.

2.

The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD.

Al-Shair K, Kolsum U, Singh D, Vestbo J.

Lung. 2016 Dec;194(6):889-895. Epub 2016 Aug 22.

3.

Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.

Subramanian DR, Gupta S, Burggraf D, Vom Silberberg SJ, Heimbeck I, Heiss-Neumann MS, Haeussinger K, Newby C, Hargadon B, Raj V, Singh D, Kolsum U, Hofer TP, Al-Shair K, Luetzen N, Prasse A, Müller-Quernheim J, Benea G, Leprotti S, Boschetto P, Gorecka D, Nowinski A, Oniszh K, Castell WZ, Hagen M, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Koczulla AR, Gut I, Hohlfeld J, Welte T, Lavae-Mokhtari M, Ziegler-Heitbrock L, Brightling C, Parr DG.

Eur Respir J. 2016 Jul;48(1):92-103. doi: 10.1183/13993003.01878-2015. Epub 2016 May 26.

4.

Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).

Al-Shair K, Muldoon EG, Morris J, Atherton GT, Kosmidis C, Denning DW.

Respir Med. 2016 May;114:117-22. doi: 10.1016/j.rmed.2016.03.020. Epub 2016 Apr 2.

5.

Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis.

Al-Shair K, Atherton GT, Harris C, Ratcliffe L, Newton PJ, Denning DW.

Clin Infect Dis. 2013 Sep;57(6):828-35. doi: 10.1093/cid/cit411. Epub 2013 Jun 20.

6.

Validity and reliability of the St. George's Respiratory Questionnaire in assessing health status in patients with chronic pulmonary aspergillosis.

Al-Shair K, Atherton GTW, Kennedy D, Powell G, Denning DW, Caress A.

Chest. 2013 Aug;144(2):623-631. doi: 10.1378/chest.12-0014.

PMID:
23188518
7.

Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale.

Al-shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA, Sharafkhaneh A, Vestbo J; ECLIPSE investigators.

Health Qual Life Outcomes. 2012 Aug 23;10:100. doi: 10.1186/1477-7525-10-100.

8.

Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD.

Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J.

Respir Res. 2011 Jan 5;12:3. doi: 10.1186/1465-9921-12-3.

9.

Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale.

Al-shair K, Kolsum U, Berry P, Smith J, Caress A, Singh D, Vestbo J.

Thorax. 2009 Nov;64(11):950-5. doi: 10.1136/thx.2009.118109. Epub 2009 Aug 30.

PMID:
19720608
10.

Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD.

Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J.

Respir Med. 2009 Oct;103(10):1572-9. doi: 10.1016/j.rmed.2008.11.021. Epub 2009 Jun 26.

Supplemental Content

Loading ...
Support Center